AngioDynamics Forecast and Stock Analysis
Technical ANGO stock analysis for February 15, 2019.
AngioDynamics gained 1.34% in the last trading day, rising from $23.15 to $23.46 , and has now gained 11 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. The price has risen in 10 of the last 10 days and is up by 11.13% over the past 2 weeks. Volume fell in the last day by -80 907 shares, and in total, 109 887 shares bought and sold for approximately $2.58 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the ANGO stock was $23.46. This is 1.34% more than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 2.17% from a day low at $23.07 to a day high of $23.57.
30 day high of the ANGO stock price was $23.57 and low was $20.09.
90 day high was $23.57 and low was $18.11.
52 week high for the AngioDynamics - $24.49 and low - $15.26.
AngioDynamics has broken the wide and weak rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at $22.64, a level that may pose a second chance to hit a runner. According to fan-theory $25.65 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.
AngioDynamics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $22.85 and $21.19. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday January 29, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSI14 is 93 and the stock is extremely overbought on RSI14, but may also ontinue to gain. Some stocks see their best performance while being overbought, but very seldom does RSI remain so high for a long time without short corrections. Risk has therefore increased and larger daily movements can be expected for the next couple of days.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $21.52 and $21.02.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AngioDynamics finds support just below today's level at $21.52. If this is broken, then the next support from accumulated volume will be at $21.02 and $19.23.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.50 between high and low, or 2.17%. For the last week, the stock has had a daily average volatility of 2.10%.
The stock is extremely overbought on RSI14 (93). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken. Since the AngioDynamics has been rising for 11 days in a row, the risk for the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.
Our recommended stoploss: $22.71 (-3.22%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 93 and this increases the risk substantially. There is a buy signal from pivot bottom found 13 days ago.)
Very Low Low Medium High Very High
AngioDynamics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.